Rus Eng
Main / Company's news / Petr Rodionov moderated the session titled “The growth of domestic production and the development of local producers” at the Russian Pharmaceutical Forum organised by the Adam Smith Institute

Petr Rodionov moderated the session titled “The growth of domestic production and the development of local producers” at the Russian Pharmaceutical Forum organised by the Adam Smith Institute

19 June 2014

From 17 to 19 June, St. Petersburg hosted the 20th Anniversary Special Russian Pharmaceutical Forum organised by the Adam Smith Institute. The largest in industry, this international forum annually brings together more than 600 participants from 28 countries and 100 speakers of the highest level, including management of some of the leading pharmaceutical companies, both local and foreign, doing business in Russia, as well as representatives of government agencies and industry experts.

GEROPHARM, Group of Companies annually takes part in this remarkable event for the industry. This year, it was for Petr Rodionov, Director General at GEOPHARM, to moderate one of the forum’s pivotal sessions headlined as“The growth of domestic production and the development of local producers.”

The event featured strategy presentations delivered by the following spokespersons on behalf of the following Russian companies: Vasily Ignatyev, CEO at R-PHARM, CJSC; Denis Chetverikov, President at AKRIKHIN, OJSC, Aleksander Khromov, CEO at CYTOMED, CJSC, member of the Board of Directors at VERTEX, CJSC, Timofey Petrov, CEO at PHARMSYNTHEZ, OJSC. Alina Lavrentyeva, Partner and Pharmaceutical Advisory Practice Leader at PwC Russia, prepared an interesting analytical review by way of generalisation of possible localisation strategies.

During the session, the participants discussed the results of what has been done over the last 5–7 years in the industry under the PHARMA-2020, and how the strategies of Russian companies and companies with Russian capital have changed. Localisation as an element of competition, partnerships and agreements, expansion of geographical presence and localisation in foreign markets, new approaches to the formation of the product portfolio, innovation as a factor of successful development – these are just a few of the issues that they were able to discuss during the one-and-a-half hours of live conversation.

“Today, we are witnessing, in fact, the completion of the industrialisation phase,” said Petr Rodionov, concluding the debate. “We have seen an advanced pharmaceutical industry emerge from the ground up in the country, reducing the technology gap between us and Western manufacturers. In many ways, it is true. And the prejudice that has been imposed on us for many years, namely that there is no place for technology or innovation in Russia, is, in fact, irrelevant now; it does not work in the pharmaceutical industry. It is pointless to draw endless parallels with the 1990s, today we live in a new reality. Today we have a whole generation of young professionals, of new manufacturing businesses, innovative companies coming out bravely and boldly to face the challenges of not only the Russian market, but of the global one, too.”

Closing the session, Mr. Rodionov expressed his gratitude to all the contributors for their excellent presentations, interesting speeches, and the topics that have been touched upon, and wished everyone fruitful work, new partnerships, and successful localisation in Russia.

You are a health care professional?

Go up